This is a translation of the original article in Portuguese. Read the original (Português).
Hundreds of children and teenagers in England have been prescribed weight-loss pens. Data obtained by the British newspaper The Guardian shows 419 prescriptions for GLP-1 drugs, such as Wegovy and Mounjaro, were issued to people under 18 in the financial year 2025 to 2026.
The figures also indicate that another 341 prescriptions were recorded between April and July this year. Among the patients are children under 12. The information was published in the print edition of the British newspaper The Independent, on page 51, based on the data revealed by the Guardian.
GLP-1 medicines have grown in popularity in recent years as treatments for obesity and diabetes. In Brazil, so-called weight-loss pens have also become a frequent topic, and their use by minors raises questions about safety and about the limits of prescribing, issues that could reach any family.
The English numbers show that prescribing these drugs to this group is already happening on a scale that draws attention, including among the youngest patients. The April-to-July data, with 341 records in just a few months, indicates that the pace remains significant this year.
In the Brazilian case, rules on use in children and adolescents and the role of Brazil’s National Health Surveillance Agency (Anvisa) over these drugs are points readers should follow, as well as the rise of childhood obesity in the country, which is at the root of the debate over more intensive treatments for this group.
Reporting from The Independent (Reino Unido, edição impressa, p. 51: dados obtidos pelo The Guardian sobre prescrições de canetas para emagrecer a crianças na Inglaterra).
Deixe um comentário